Optimizing treatment strategies for intermediate-to-high risk pulmonary embolism
Int J Cardiol
.
2023 Nov 1:390:131212.
doi: 10.1016/j.ijcard.2023.131212.
Epub 2023 Jul 26.
Author
Raquel Barba-Martín
1
Affiliation
1
Internal Medicine Department, Hospital Universitario Rey Juan Carlos, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz, Madrid, Spain. Electronic address: raquel.barba@hospitalreyjuancarlos.es.
PMID:
37506975
DOI:
10.1016/j.ijcard.2023.131212
No abstract available
Publication types
Editorial
Comment
MeSH terms
Fibrinolytic Agents / therapeutic use
Humans
Pulmonary Embolism* / diagnosis
Pulmonary Embolism* / drug therapy
Thrombolytic Therapy
Treatment Outcome
Substances
Fibrinolytic Agents